Department of Medical Biosciences, Umeå University, Umeå, Sweden.
Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
J Lipid Res. 2022 Jan;63(1):100144. doi: 10.1016/j.jlr.2021.100144. Epub 2021 Oct 26.
LPL is a key player in plasma triglyceride metabolism. Consequently, LPL is regulated by several proteins during synthesis, folding, secretion, and transport to its site of action at the luminal side of capillaries, as well as during the catalytic reaction. Some proteins are well known, whereas others have been identified but are still not fully understood. We set out to study the effects of the natural variations in the plasma levels of all known LPL regulators on the activity of purified LPL added to samples of fasted plasma taken from 117 individuals. The enzymatic activity was measured at 25°C using isothermal titration calorimetry. This method allows quantification of the ability of an added fixed amount of exogenous LPL to hydrolyze triglyceride-rich lipoproteins in plasma samples by measuring the heat produced. Our results indicate that, under the conditions used, the normal variation in the endogenous levels of apolipoprotein C1, C2, and C3 or the levels of angiopoietin-like proteins 3, 4, and 8 in the fasted plasma samples had no significant effect on the recorded activity of the added LPL. Instead, the key determinant for the LPL activity was a lipid signature strongly correlated to the average size of the VLDL particles. The signature involved not only several lipoprotein and plasma lipid parameters but also apolipoprotein A5 levels. While the measurements cannot fully represent the action of LPL when attached to the capillary wall, our study provides knowledge on the interindividual variation of LPL lipolysis rates in human plasma.
LPL 是血浆甘油三酯代谢的关键因素。因此,LPL 在合成、折叠、分泌和运输到毛细血管腔侧的作用部位以及催化反应过程中受到几种蛋白质的调节。一些蛋白质是众所周知的,而其他一些蛋白质已经被发现,但仍不完全了解。我们着手研究所有已知 LPL 调节剂在血浆水平上的自然变化对从 117 个人的禁食血浆样本中添加的纯化 LPL 活性的影响。在 25°C 下使用等温滴定量热法测量酶活性。该方法通过测量产生的热量来定量测量添加的固定量外源性 LPL 水解血浆样品中富含甘油三酯的脂蛋白的能力。我们的结果表明,在使用的条件下,禁食血浆样本中载脂蛋白 C1、C2 和 C3 的内源性水平或血管生成素样蛋白 3、4 和 8 的水平的正常变化对添加的 LPL 的记录活性没有显著影响。相反,LPL 活性的关键决定因素是与 VLDL 颗粒平均大小强烈相关的脂质特征。该特征不仅涉及几种脂蛋白和血浆脂质参数,还涉及载脂蛋白 A5 水平。虽然这些测量不能完全代表附着在毛细血管壁上的 LPL 脂解作用,但我们的研究提供了有关人类血浆中 LPL 脂解速率个体间差异的知识。